SPOCK1 protein emerges as a grim prognostic marker in head and neck cancers
New research links elevated SPOCK1 levels to significantly reduced overall survival in head and neck squamous cell carcinomas, suggesting aggressive ...
New research links elevated SPOCK1 levels to significantly reduced overall survival in head and neck squamous cell carcinomas, suggesting aggressive ...
A systematic review and meta-analysis of 23 studies and 547 patients finds that CD19-directed CAR T-cell therapy delivers encouraging one-year ...
A retrospective study of 138 premenopausal women with hormone receptor-positive, HER2-positive breast cancer found no independent survival benefit from adding ...
A retrospective study of 7,640 Chinese children treated under the CCCG-ALL-2015 protocol shows that serious adverse events, dominated by infections ...
A prospective controlled study in BMC Medicine found that adding hepatic arterial infusion chemotherapy to lenvatinib and a PD-1 inhibitor ...
Researchers in China have built and validated a statistical survival calculator for young patients with upper tract urothelial carcinoma using ...
A two-center retrospective study found that adding TACE or HAIC to targeted-immunotherapy nearly doubled median overall survival in advanced hepatocellular ...
A network meta-analysis of eight randomized trials finds that immune checkpoint inhibitors combined with anti-VEGF therapy outperform other immunotherapy combinations ...
A multicenter study of 347 lung cancer patients found that achieving a complication-free, complete surgical course after neoadjuvant therapy independently ...
A retrospective study of 25 patients suggests that adding the anti-PD-1 antibody pucotenlimab to concurrent radiochemotherapy produced tumor responses and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine